surgery

Today announced that the U.

Celator Pharmaceuticals’ CPX-351 receives FDA Fast Monitor designation for secondary AML treatment Celator Pharmaceuticals, Inc vardénafil avis des utilisateurs . , a biopharmaceutical company that’s transforming the research of mixture therapy and developing items to improve patient outcomes in tumor, today announced that the U.S. Food and Medication Administration granted Fast Track designation for CPX-351 for the treatment of elderly patients with secondary Acute Myeloid Leukemia . Continue reading

Published in the Proceedings of the National Academy of Sciences.

Anti-inflammatory coxib medications inhibit aspirin’s protective qualities A new research conducted at Ben-Gurion University of the Negev reveals that Celebrex and additional anti-inflammatory coxib medications may counter the positive effects of aspirin in preventing bloodstream clots. The research, published in the Proceedings of the National Academy of Sciences , indicates that people who are taking aspirin and coxibs together are in fact inhibiting the aspirin’s performance in preventing heart attacks and strokes. ‘This obtaining strongly suggests that human beings who are consuming coxibs and a low dose of aspirin simultaneously are exposed to a greater threat of cardiovascular occasions,’ stated Professor Gilad Rimon, Section of Clinical Pharmacology, Ben-Gurion University of the Negev in Israel ?widely spread condition . Continue reading